These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32708601)

  • 1. Inflammatory Breast Carcinoma: Elevated microRNA miR-181b-5p and Reduced miR-200b-3p, miR-200c-3p, and miR-203a-3p Expression as Potential Biomarkers with Diagnostic Value.
    Fahim SA; Abdullah MS; Espinoza-Sánchez NA; Hassan H; Ibrahim AM; Ahmed SH; Shakir G; Badawy MA; Zakhary NI; Greve B; El-Shinawi M; Götte M; Ibrahim SA
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer.
    Ahmed SH; Espinoza-Sánchez NA; El-Damen A; Fahim SA; Badawy MA; Greve B; El-Shinawi M; Götte M; Ibrahim SA
    PLoS One; 2021; 16(4):e0250642. PubMed ID: 33901254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic potential of miR-200 family members in gingival crevicular fluid for chronic periodontitis: correlation with clinical parameters and therapeutic implications.
    Yu SL
    BMC Oral Health; 2023 Jul; 23(1):532. PubMed ID: 37525201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Cell-free miRNA Expression and its Association with Clinicopathologic Features in Inflammatory and Non- Inflammatory Breast Cancer.
    Hamdi K; Blancato J; Goerlitz D; Islam M; Neili B; Abidi A; Gat A; Ayed FB; Chivi S; Loffredo C; Jillson I; Elgaaied AB; Marrakchi R
    Asian Pac J Cancer Prev; 2016; 17(4):1801-10. PubMed ID: 27221856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary-derived extracellular vesicle microRNAs as non-invasive diagnostic biomarkers for early-stage renal cell carcinoma.
    Zhang Y; Zhu YY; Chen Y; Zhang L; Wang R; Ding X; Zhang H; Zhang CY; Zhang C; Gu WJ; Wang C; Wang JJ
    Clin Chim Acta; 2024 Jan; 552():117672. PubMed ID: 37995985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
    Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
    Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNAs in Sera of Tunisian patients discriminate between inflammatory breast cancer and non-inflammatory breast cancer.
    Hamdi K; Goerlitz D; Stambouli N; Islam M; Baroudi O; Neili B; Benayed F; Chivi S; Loffredo C; Jillson IA; Benammar Elgaaied A; Blancato JK; Marrakchi R
    Springerplus; 2014; 3():636. PubMed ID: 26034677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer.
    Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L
    Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressiveness.
    Lerebours F; Cizeron-Clairac G; Susini A; Vacher S; Mouret-Fourme E; Belichard C; Brain E; Alberini JL; Spyratos F; Lidereau R; Bieche I
    Int J Cancer; 2013 Oct; 133(7):1614-23. PubMed ID: 23526361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process.
    Wang HY; Liu YN; Wu SG; Hsu CL; Chang TH; Tsai MF; Lin YT; Shih JY
    Cancer Biomark; 2020; 28(3):351-363. PubMed ID: 32417760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.
    Turkistani S; Sugita BM; Fadda P; Marchi R; Afsari A; Naab T; Apprey V; Copeland RL; Campbell MC; Cavalli LR; Kanaan Y
    BMC Cancer; 2021 Jul; 21(1):861. PubMed ID: 34315420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
    Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M
    Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of five miRNAs in papillary thyroid carcinomas.
    Qiao DH; He XM; Deng X; Ji YC; Yang H; Cheng L; Zhou XY
    J Clin Lab Anal; 2021 Sep; 35(9):e23907. PubMed ID: 34268792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
    Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
    Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.